• News
  • Tunnel vision or global outlook? Global pharm...
News - published on 16 Jul 2020

Tunnel vision or global outlook? Global pharma's dependency on the US

COVID-19 is a litmus test of whether health systems can pool assets and expertise and fairly distribute resources so that patients worldwide can benefit equally. To pass the test, all pharma companies will need to play a part, considering the scale of the need for better access to medicine across the globe. There are signs that "Big Pharma's" preoccupation with the US market and earning high profit margins in lucrative markets translates into a harmful tunnel vision when it comes to global health.

By Jayasree K. Iyer, Executive Director, Access to Medicine Foundation

Explore further

Get in touch

Back to top |